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EDITORIAL
Why do we have to invoke genetic susceptibility
for diabetic nephropathy?
Kidney disease is one of the most serious and costly years ago we and other workers showed that the function
complications of diabetes. However, the kidney does not of a red-cell membrane transport system, the sodium-
fail in all people with diabetes. Sometimes this is because lithium countertransport, which had been associated
other competing causes, such as cardiovascular disease, with essential hypertension, was abnormally high in dia-
lead to death before end-stage renal failure intervenes, betic patients with diabetic nephropathy [3, 4]. Most
but in many cases, in spite of long-standing diabetes, the of the interindividual variability of the activity of this
function of the kidney is preserved. The incidence of transport system was believed to be explained by genetic
diabetic nephropathy increases up to 17 years from the influence, a view recently confirmed by the finding of a
initial diagnosis of diabetes and then sharply declines. close concordance of sodium-lithium countertransport
Hyperglycemia, though critically necessary for kidney activity in identical twins discordant for type 1 diabetes
disease development, is insufficient to totally account [5]. However, the sodium-lithium countertransport is an
for it. in vitro artifactual system that does not operate in vivo
Why then are some diabetic people susceptible to and and its relevance to the pathogenesis of diabetic renal
others protected from renal disease? Familial factors are disease remains uncertain. The sodium-hydrogen anti-
important. A diabetic sibling of a person with type 1 port is an integral plasma membrane protein that cata-
diabetes and nephropathy has a 72% cumulative risk of lyzes the electroneutral exchange of extracellular sodium
developing renal disease, while a diabetic sibling of a for intracellular hydrogen and regulates major cellular
person with type 1 diabetes but without nephropathy events such as intracellular pH, cell volume and stimulus-
only has a 25% risk, a staggering 47% difference [1]. response coupling and cell proliferation. Of the five iso-
Diabetic patients who develop nephropathy have a forms described the NHE1 is the most widely studied.
higher incidence of arterial hypertension and cardiovas- Increased sodium-hydrogen antiport activity was first re-
cular disease. Indeed, a predisposition to hypertension ported in leukocytes and in red blood cells of type 1
and coronary heart disease may be an important determi- diabetic patients with microalbuminuria or proteinuria
nant of susceptibility to renal disease, since raised blood as well as in subjects with arterial hypertension [6]. How-
pressure, frequency of cardiovascular disease and insulin ever, because the activity and the expression level of
resistance are significantly more prevalent in first degree this antiporter is modulated by a large variety of stimuli
relatives of diabetic patients with nephropathy [2]. including growth factors, tumor promoters, hormones,
All these observations are consistent with a genetic changes in cell volume and extracellular pH, these early
predisposition to diabetic nephropathy and are by and studies could not exclude the possibility that the phe-
large true for both type 1 and type 2 diabetes. Clinical nomenon observed was a consequence of the disturbed
manifestations (such as renal disease, arterial hyperten- metabolic milieu of the diabetes state. More recently we
sion, etc.), however, are complex multifactorial pheno- were able to show that this abnormal phenotype was
types that are affected by an interaction of environmen- preserved in vitro in cultured skin fibroblasts after sev-
tal, familial and genetic influences and are far removed eral passages [7], and Ng et al [8] confirmed this finding
from a direct gene effect. To get closer to the genetic in immortalized lymphoblasts of type 1 diabetic patients
basis and pathogenic mechanisms of diabetic nephropa- with nephropathy. The elevated maximal velocity of
thy, researchers have attempted to move down from the Na1/H1 exchanger was due to an increased turnover rate
height of complexity, at the whole organism level, to per site. The speculation was that because the anomaly
the simple DNA sequence alteration by dissecting the persisted in culture in vitro, the activity of the Na1/H1
disease phenotype into several intermediate phenotypes antiporter was intrinsically determined. The article by
at the different levels of biological organization. Some Trevisan and his colleagues in this issue [9] showing a
very close concordance for sodium-hydrogen antiport
activity in cultured skin fibroblasts of type 1 diabeticKey words: diabetes, genetic predisposition, sodium-hydrogen anti-
port, extracellular matrix, phenotype. siblings, makes a compelling case in favor of the view that
these in vitro cell phenotypic characteristics are under 1999 by the International Society of Nephrology
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genetic control. Trevisan et al also provide supportive to diabetes. Genetic dissection of a complex trait such
as diabetic nephropathy, which is likely to involve anevidence that the degree of proteinuria and metabolic
control do not explain the concordance in Na1/H1 ex- interaction between more than one gene, environmental
factors and compensatory factors, may prove arduous.changer activity between diabetic sibling pairs. A possi-
bility exists that the genetic alteration that explains the In the meantime, the use of reliable intermediate pheno-
types in our quest for early diagnosis, risk assessmentoveractivity of the Na1/H1 antiporter is not located in
the Na1/H1 exchanger gene(s), but resides in some other and targeting of preventive and intensive therapies
should not be discounted.process that carries as an obligate step an increase in
antiporter activity.
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